Patents by Inventor Karina Martin

Karina Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AUTOANTIBODY BIOMARKERS OF OVARIAN CANCER
    Publication number: 20220365088
    Abstract: The present invention relates to the identification of biological markers of ovarian cancer. Specifically, cancer-associated autoantibodies to ANXA1, ARP3, SAHH, SERPH, ARAP1, OTUB1, ATP1A1, UBA1, and CFAH have been identified in subjects with early stage ovarian cancer. These autoantibodies can be utilised for a range of purposes including methods for detecting ovarian cancer, methods for screening for early stage ovarian cancer, and methods for assessing treatment response as well as disease progression and recurrence. The autoantibodies also represent prognostic markers of ovarian cancer development.
    Type: Application
    Filed: May 27, 2022
    Publication date: November 17, 2022
    Applicant: ADELAIDE RESEARCH & INNOVATION PTY LTD
    Inventors: Peter Hoffmann, Martin Oehler, Karina Martin
  • Autoantibody biomarkers of ovarian cancer
    Patent number: 11371993
    Abstract: The present invention relates to the identification of biological markers of ovarian cancer. Specifically, cancer-associated autoantibodies to ANXA1, ARP3, SAHH, SERPH, ARAP1, OTUB1, ATP1A1, UBA1, and CFAH have been identified in subjects with early stage ovarian cancer. These autoantibodies can be utilised for a range of purposes including methods for detecting ovarian cancer, methods for screening for early stage ovarian cancer, and methods for assessing treatment response as well as disease progression and recurrence. The autoantibodies also represent prognostic markers of ovarian cancer development.
    Type: Grant
    Filed: January 11, 2019
    Date of Patent: June 28, 2022
    Assignee: ADELAIDE RESEARCH & INNOVATION PTY LTD
    Inventors: Peter Hoffmann, Martin Oehler, Karina Martin
  • AUTOANTIBODY BIOMARKERS OF OVARIAN CANCER
    Publication number: 20190219584
    Abstract: The present invention relates to the identification of biological markers of ovarian cancer. Specifically, cancer-associated autoantibodies to ANXA1, ARP3, SAHH, SERPH, ARAP1, OTUB1, ATP1A1, UBA1, and CFAH have been identified in subjects with early stage ovarian cancer. These autoantibodies can be utilised for a range of purposes including methods for detecting ovarian cancer, methods for screening for early stage ovarian cancer, and methods for assessing treatment response as well as disease progression and recurrence. The autoantibodies also represent prognostic markers of ovarian cancer development.
    Type: Application
    Filed: January 11, 2019
    Publication date: July 18, 2019
    Applicant: ADELAIDE RESEARCH & INNOVATION PTY LTD
    Inventors: Peter Hoffmann, Martin Oehler, Karina Martin
  • AUTOANTIBODY BIOMARKERS OF OVARIAN CANCER
    Publication number: 20160291025
    Abstract: The present invention relates to the identification of biological markers of ovarian cancer. Specifically, cancer-associated autoantibodies to ANXA1, ARP3, SAHH, SERPH, ARAP1, OTUB1, ATP1A1, UBA1, and CFAH have been identified in subjects with early stage ovarian cancer. These autoantibodies can be utilised for a range of purposes including methods for detecting ovarian cancer, methods for screening for early stage ovarian cancer, and methods for assessing treatment response as well as disease progression and recurrence. The autoantibodies also represent prognostic markers of ovarian cancer development.
    Type: Application
    Filed: September 18, 2014
    Publication date: October 6, 2016
    Applicant: ADELAIDE RESEARCH & INNOVATION PTY LTD
    Inventors: Peter Hoffmann, Martin Oehler, Karina Martin